Merck gives Moderna $ 250 million for cancer mRNA vaccine
The drug company could "cash in on" the mRNA cancer vaccine it is helping to deliver.
The drug company could "cash in on" the mRNA cancer vaccine it is helping to deliver.
It is called Molnupiravir and for days we have been talking about nothing but this antiviral that can help us give a perhaps decisive blow to Covid. But how does it work?
Alberto Robiati and Gianluca Riccio guide readers through scenarios of the future: the opportunities, risks and possibilities we have to create a possible tomorrow.
News about the world of tomorrow.
We give news about the future of technology, science and society: if there is one thing that is about to arrive, it has already arrived here.
Category
Language editions
© 2024 Near future - This work is distributed under license Creative Commons Attribution 4.0 International.